A carregar...
Vemurafenib and cutaneous adverse events - report of five cases
Vemurafenib is a selective inhibitor of V600E-mutant BRAF protein used to treat metastatic and unresectable melanoma. Clinical trials have shown increased overall survival and progression-free survival in patients treated with Vemurafenib. However, cutaneous adverse events are common during treatmen...
Na minha lista:
| Publicado no: | An Bras Dermatol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Sociedade Brasileira de Dermatologia
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4540563/ https://ncbi.nlm.nih.gov/pubmed/26312729 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1590/abd1806-4841.20153841 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|